SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001792044-24-000017
Filing Date
2024-05-09
Accepted
2024-05-09 16:03:24
Documents
110
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vtrs-20240331.htm   iXBRL 10-Q 1828453
2 EX-31.1 ex_311xvtrsx20240331.htm EX-31.1 8579
3 EX-31.2 ex_312xvtrsx20240331.htm EX-31.2 8640
4 EX-32 ex_32xvtrsx20240331.htm EX-32 6334
  Complete submission text file 0001792044-24-000017.txt   11960490

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtrs-20240331.xsd EX-101.SCH 78761
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtrs-20240331_cal.xml EX-101.CAL 95447
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtrs-20240331_def.xml EX-101.DEF 649808
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtrs-20240331_lab.xml EX-101.LAB 931914
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtrs-20240331_pre.xml EX-101.PRE 868601
114 EXTRACTED XBRL INSTANCE DOCUMENT vtrs-20240331_htm.xml XML 1884998
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

IRS No.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39695 | Film No.: 24930348
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)